Medline (MDLN) Liabilities and Shareholders Equity (2024 - 2026)
Medline (MDLN) posted quarterly Liabilities and Shareholders Equity of $39.0 billion for Q1 2026, up 1.38% quarter-over-quarter from $38.5 billion in Q4 2025.
Medline (MDLN) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Medline (MDLN) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $39.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $39.0 billion; the TTM figure through Mar 2026 stood at $113.5 billion (changed N/A YoY), while the FY2025 annual figure was $38.5 billion, up 6.97% from the prior year.
- Liabilities and Shareholders Equity improved to $39.0 billion in Q1 2026 per MDLN's latest filing, from $38.5 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $39.0 billion in Q1 2026 and bottomed at $36.0 billion in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $37.8 billion across 3 years, with a median of $38.5 billion in 2025.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 6.97% in 2025 and fell as far as 6.97% in 2025.
- Medline's Liabilities and Shareholders Equity stood at $36.0 billion in 2024, then climbed by 6.97% to $38.5 billion in 2025, then gained by 1.38% to $39.0 billion in 2026.
- Business Quant data shows MDLN's Liabilities and Shareholders Equity at $39.0 billion in Q1 2026, $38.5 billion in Q4 2025, and $36.0 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 6.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 39.35 Bn |
| Mar 28, 2026 | 39.01 Bn |
| Dec 31, 2025 | 38.48 Bn |
| Dec 31, 2024 | 35.98 Bn |